Zambelli, A., D'Incalci, M. (2023). Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives. FRONTIERS IN ONCOLOGY, 12 [10.3389/fonc.2022.1115342].

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives

Zambelli, A;
2023

Editoriale, introduzione, contributo a forum/dibattito
eribulin and related compounds; lurbinectedin; marine drugs; solid tumor; trabectedin;
English
25-gen-2023
2023
12
1115342
open
Zambelli, A., D'Incalci, M. (2023). Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives. FRONTIERS IN ONCOLOGY, 12 [10.3389/fonc.2022.1115342].
File in questo prodotto:
File Dimensione Formato  
Zambelli-2023-Frontiers in Oncology-VoR.pdf

accesso aperto

Descrizione: This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 237.09 kB
Formato Adobe PDF
237.09 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/526668
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact